| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $29.3B | $33.1B | $38.3B | $46.8B | $27.3B | $15.1B | $24.5B | $27.2B |
| Cost of Revenue | $29.9B | $33.5B | $35.9B | $42.2B | $26.4B | $16.7B | $23.6B | $26.6B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-0.1B | $-0.7B | $3.0B | $4.2B | $0.6B | $-1.4B | $0.1B | $-0.4B |
| Net Income | $-0.2B | $-0.5B | $2.1B | $2.9B | $0.2B | $-1.4B | $0.1B | $-0.4B |
| EPS (Basic) | $-1.39 | $-4.59 | $17.13 | $23.47 | $1.92 | $-11.64 | $2.66 | $1.11 |
| EPS (Diluted) | $-1.39 | $-4.60 | $16.52 | $22.84 | $1.90 | $-11.64 | $0.44 | $1.10 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.0B | $12.7B | $14.4B | $13.5B | $11.6B | $10.5B | $9.1B | $8.0B |
| Current Assets | $4.5B | $4.5B | $6.6B | $6.5B | $5.2B | $3.9B | $3.8B | $3.2B |
| Cash & Equivalents | $0.5B | $0.5B | $1.8B | $2.2B | $1.3B | $1.6B | $0.8B | $0.6B |
| Total Liabilities | $7.6B | $7.0B | $7.8B | $8.5B | $9.1B | $8.3B | $5.5B | $4.8B |
| Current Liabilities | $3.7B | $3.6B | $4.2B | $5.2B | $3.8B | $2.5B | $2.5B | $2.1B |
| Stockholders' Equity | $5.3B | $5.5B | $6.5B | $4.9B | $1.9B | $1.6B | $3.0B | $2.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.1B | $0.0B | $1.3B | $4.8B | $0.5B | $-0.6B | $0.9B | $0.8B |
| Investing Cash Flow | $-0.5B | $-1.0B | $-0.3B | $-1.0B | $-0.4B | $-1.0B | $-0.7B | $-0.7B |
| Capital Expenditures | $0.7B | $0.4B | $0.7B | $0.6B | $0.2B | $0.2B | $0.4B | $0.3B |
| Financing Cash Flow | $0.6B | $-0.2B | $-1.4B | $-2.9B | $-0.4B | $2.5B | $-0.0B | $-0.1B |